You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the Indian Subcontinent.
Any and all information provided is intended for general overview. Viewers taking any decision based on the information provided herein are requested to seek professional advice.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
BLOOD PRESSURE PROCEDURE
The renal denervation blood pressure procedure provides another management option for people with uncontrolled high blood pressure.*1–3
The renal denervation blood pressure procedure calms excessively active nerves connected to the kidneys that may be contributing to your high blood pressure.4
Adverse events include, but are not limited to, bruising and pain. Results may vary.
The renal denervation blood pressure procedure usually only takes up one day of your schedule, and can be done on an outpatient basis with your doctor's approval.
Always follow the instructions specified by your doctor or the nursing staff. Always follow the discharge instructions provided by your physician after your procedure.
Through three years in a patient registry.
Kandzari DE, Böhm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet. June 9, 2018;391(10137):2346–2355.
Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. May 2, 2020;395(10234):1444–1451.
Mahfoud F, Mancia G, Schmieder R, et al. Blood pressure and MACE reductions after renal denervation: 3-year Global Symplicity Registry results. Presented at PCR e-course 2022.
Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. March 5, 2016;387(10022):957–967.
Mahfoud F, Mancia G, Schmieder R, et al. Renal denervation in high-risk patients with hypertension. J Am Coll Cardiol. June 16, 2020;75(23):2879–2888.
Böhm M, Mahfoud F, Williams B, et al. Renal denervation with Symplicity Spyral™ catheter in the Global Symplicity Registry: Safety and efficacy at 3 years. Poster. TCT 2019.
Medtronic data on file.